Skip to main content

Table 2 Characteristics of recurrence and second debulking surgery

From: Salvage cytoreductive surgery for patients with recurrent endometrial cancer: a retrospective study

  Number of patients (%)
Largest size of recurrence (cm)  
  Median (range) 6 (1-25)
Sites of recurrence  
  Central pelvic-vaginal 6 (8.0)
  Pelvic 25 (33.3)
  Intro-abdorminal alone 3 (4.0)
  Retroperitoneal alone 8 (10.7)
  Pelvic and intra-abdominal 17 (22.7)
  Pelvic and retroperitoneal 3 (4.0)
  Intra-abdominal and retroperitoneal 1 (1.3)
  Vaginal 5 (6.7)
  Inguinal 5 (6.7)
  Abdominal wall 1 (1.3)
  Lung 1 (1.3)
  Ascites 8 (10.5)
Multiplicity of recurrence  
  Solitary 35 (46.7)
  Multiple 40 (53.3)
Surgical procedures  
  Tumor mass resection 36 (51.4)
  Pelvic lymph node resection 12 (16.0)
  Para-aortic lymph node resection 10 (13.3)
  Inguinal lymph node resection 4 (5.3)
  Omentectomy 17 (22.7)
  Appendectomy 9 (12.0)
  Mesenterectomy 5 (6.7)
  Large-bowel resection 19 (25.0)
  Small-bowel resection 6 (8.0)
Colostomy 6 (8.0)
  Patial abdominal wall resection 3 (4.0)
  Upper vaginectomy 18 (24.0)
  Vulvectomy 1 (1.3)
  Partial urethrectomy 1 (1.3)
  Partial cystectomy and ureterectomy 2 (2.7)
  Ureteral stents 6 (8.0)
  Partial gastrectomy 1 (1.3)
  Radical pulmonary lobe resection 1 (1.3)
  Biopsy alone 4 (5.3)
Operative time (minutes)  
  Median (range) 150 (30-430)
Blood transfusion 42 (56.0)
  Median (range, blood unit) 2 (1-13)
Median hospitalized day 20 (6-130)
Residual disease (cm)  
  None 43 (57.3)
  0.1~1 15 (20.0)
  1~2 6 (8.0)
  >2 11 (14.7)
Complications 9 (12.0)
  Iliac artery injury 1 (1.33)
  Ureteral injury 2 (2.67)
  Acute renal failure 1 (1.33)
  Urethrovaginal fistula 1 (1.33)
  Bowel obstruction 1 (1.33)
  Deep vein thrombosis 1 (1.33)
  Drug allergy 1 (1.33)
  Hydronephrosis 1 (1.33)